Shares of AnaptysBio fell 14% in pre-market trading on Friday after the US drug developer and Tesaro, a unit of UK pharma ...

By Kamal Choudhury (Reuters) -Shares of AnaptysBio fell more than 5% on Friday after the U.S. drug developer and GSK's oncology unit, Tesaro, filed lawsuits against each other, with both claiming a ...

Markets looked set to open under pressure, reflecting mounting doubts about lofty valuations, especially in tech and ...

Dow Jones Top Company Headlines at 7 AM ET: Paramount, Comcast and Netflix Submit Bids for Warner Bros. Discovery | GSK, ... Paramount, Comcast and Netflix Submit Bids for Warner Bros. Discovery Of ...

GSK Vietnam steps up action against antimicrobial resistance, promoting rational antibiotic use and wider vaccine coverage.

Flagship Pioneering’s ecosystem scored two big-name boosts on Thursday, as GSK (LSE: GSK) and Germany’s Merck KGaA unveiled new partnerships that broaden the appeal of the Cambridge group’s ...

Drugmaker GSK said it started litigation against AnaptysBio for what it called a material breach of an agreement regarding one of its cancer treatments. GSK said its Tesaro subsidiary initiated the ...

The global glucosamine supplement market is on track for consistent expansion, projected to increase from USD 641.0 million ...

The Organisation of Pharmaceutical Producers of India (OPPI) organized its flagship Annual Summit today at Shangri-La Eros, ...